These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39033493)

  • 1. [Results of neonatal screening for spinal muscular atrophy in Hungary in 2023].
    Mikos B; Molnár MJ; Szatmári I; Monostori P; Bereczki C; Szabó AJ; Szabó L; Csősz K; Muzsik B; Velkey GJ
    Orv Hetil; 2024 Jul; 165(29):1122-1129. PubMed ID: 39033493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Our initial experiences with intravenous gene therapy for spinal muscular atrophy in children].
    Mikos B; Gergely A; Balázsfi R; Bányász E; Gyömörei B; Hantos M; Czelecz J; Jakus R; Kárász H; Zilahy M; Molnár E; Paraicz É; Csohány Á; Szénási F; Vendégh L; Fogarasi A; Velkey G
    Orv Hetil; 2020 Oct; 161(42):1806-1816. PubMed ID: 33070118
    [No Abstract]   [Full Text] [Related]  

  • 3. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating neonatal spinal muscular atrophy: A 21st century success story?
    Tizzano EF
    Early Hum Dev; 2019 Nov; 138():104851. PubMed ID: 31604576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Testing for Patients with Spinal Muscular Atrophy.
    Brandsema JF; Gross BN; Matesanz SE
    Clin Lab Med; 2020 Sep; 40(3):357-367. PubMed ID: 32718505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversy over Werdnig-Hoffmann disease and multiple system atrophy.
    Chou SM
    Curr Opin Neurol; 1993 Dec; 6(6):861-4. PubMed ID: 8293160
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on: "Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?" by Kay et al.
    Dangouloff T; Boemer F; Caberg JH; Servais L
    Genet Med; 2020 Nov; 22(11):1913-1914. PubMed ID: 32601389
    [No Abstract]   [Full Text] [Related]  

  • 10. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR.
    Czibere L; Burggraf S; Fleige T; Glück B; Keitel LM; Landt O; Durner J; Röschinger W; Hohenfellner K; Wirth B; Müller-Felber W; Vill K; Becker M
    Eur J Hum Genet; 2020 Jan; 28(1):23-30. PubMed ID: 31363188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment.
    Nishio H; Niba ETE; Saito T; Okamoto K; Takeshima Y; Awano H
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False Negative Carrier Screening in Spinal Muscular Atrophy.
    Butcher S; Smith M; Woodcock IR; Delatycki M; Ryan MM; Forbes R
    J Child Neurol; 2020 Mar; 35(4):274-277. PubMed ID: 31858866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why should a 5q spinal muscular atrophy neonatal screening program be started?
    Becker MM; Nardes F; Dangouloff T; Servais L; Araujo APQC; Gurgel-Giannetti J
    Arq Neuropsiquiatr; 2024 Oct; 82(10):1-9. PubMed ID: 39396519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
    Boylan KB; Cornblath DR
    Ann Neurol; 1992 Sep; 32(3):404-7. PubMed ID: 1416812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for spinal muscular atrophy: Anticipating an imminent need.
    Phan HC; Taylor JL; Hannon H; Howell R
    Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal Muscular Atrophy in the Treatment Era.
    Waldrop MA; Elsheikh BH
    Neurol Clin; 2020 Aug; 38(3):505-518. PubMed ID: 32703464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for spinal muscular atrophy: an impetus for newborn screening.
    EBioMedicine; 2021 Jul; 69():103507. PubMed ID: 34315607
    [No Abstract]   [Full Text] [Related]  

  • 19. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
    Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
    Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.